Results 11 to 20 of about 4,527 (138)

Mispositioned Hydrus Microstents: A Case Series Imaged with NIDEK GS-1 Gonioscope

Journal of Ophthalmology, 2022
Introduction. The Hydrus microstent has become a common procedure in glaucoma surgery intended to improve outcomes of cataract surgery to lower intraocular pressure.
Daniel Laroche, Alexander Martin, Aaron Brown, Sohail Sakkari, Chester Ng   +4 more
doaj   +5 more sources

Surgical technique to prevent malposition of the Hydrus glaucoma microstent (The “gap sign”) [PDF]

Indian Journal of Ophthalmology
The key challenge of implanting the hydrus glaucoma microstent is avoiding the tip from exiting Schlemm’s canal and diving posteriorly toward the iris root.
Nicholas H Andrew, Malak Habib
doaj   +6 more sources

Hydrus microstent implantation for surgical management of glaucoma: a review of design, efficacy and safety [PDF]

Eye and Vision, 2019
With the advent of microinvasive glaucoma surgery (MIGS), the spectrum of modalities available to manage patients with this chronic and heterogeneous condition has broadened.
Saba Samet, Jeb A. Ong, Iqbal Ike K. Ahmed   +2 more
doaj   +8 more sources

Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study

Journal of Ophthalmology, 2022
Purpose. To determine the efficacy and safety of phacoemulsification, clear lensectomy, and the Hydrus microstent (Ivantis, Inc.) in Black and Afro-Latino glaucoma patients. Method. This is a retrospective nonrandomized study of 134 Black and Afro-Latino
Daniel Laroche, Jessinta Oseni, Gideon Nkrumah, Chester Ng   +3 more
doaj   +3 more sources

Comparison of the Intraocular Pressure-Lowering Effect of Minimally Invasive Glaucoma Surgery (MIGS) iStent Inject W and Hydrus—The 12-Month Real-Life Data [PDF]

Diagnostics
Background/Objectives: To compare the efficacy and safety of Hydrus® Microstent and iStent inject® W implants, in combination with phacoemulsification, for lowering intraocular pressure (IOP) in patients with glaucoma in a real-world clinical setting ...
Cedric Weich, Julian Alexander Zimmermann, Jens Julian Storp, Ralph-Laurent Merté, Nicole Eter, Viktoria Constanze Brücher   +5 more
doaj   +3 more sources

Minimally invasive glaucoma surgery: comparison of Hydrus microstent with iStent inject in primary open-angle glaucoma [PDF]

BMJ Open Ophthalmology
Background To evaluate and compare the efficacy of a single Hydrus and double iStent inject both combined with cataract surgery for the treatment of primary open-angle glaucoma (POAG).Methods The study was designed as a prospective comparative case ...
Krishna Komzak, Penelope L Allen, Tze’Yo Toh   +2 more
doaj   +4 more sources

Twenty-Four-Hour Contact Lens Sensor Monitoring of Aqueous Humor Dynamics in Surgically or Medically Treated Glaucoma Patients [PDF]

Journal of Ophthalmology, 2019
Aim. This study assessed the 24 h circadian rhythm of intraocular pressure (IOP) using a contact lens sensor in three groups of patients with open-angle glaucoma. Methods.
Chiara Posarelli, Pierluigi Ortenzio, Antonio Ferreras, Mario Domenico Toro, Andrea Passani, Pasquale Loiudice, Francesco Oddone, Giamberto Casini, Michele Figus   +8 more
doaj   +3 more sources

Visualization of the Postoperative Position of the Hydrus^® Microstent Using Automatic 360° Gonioscopy. [PDF]

J Clin Med
Introduction: Glaucoma, one leading cause of irreversible vision loss worldwide, is primarily caused by elevated intraocular pressure (IOP). Recently, minimally invasive glaucoma surgeries (MIGSs) have become popular due to their shorter surgical times, tissue-sparing nature, and faster recovery.
Zimmermann JA, Kleemann S, Storp JJ, Weich C, Merté RL, Eter N, Brücher VC.   +6 more
europepmc   +6 more sources

The Hydrus Microstent in Pseudophakic Patients With Medically Refractory Open-angle Glaucoma

Journal of Glaucoma, 2021
Purpose: Minimally invasive glaucoma surgery (MIGS) is an emerging therapy for glaucoma. The Hydrus Microstent is a MIGS device that stents Schlemm’s canal, thereby increasing aqueous drainage and lowering intraocular pressure (IOP).
Coventon, James, Cronin, Brendan
openaire   +4 more sources

Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma [PDF]

Cochrane Database of Systematic Reviews, 2020
Glaucoma is a leading cause of irreversible blindness. A number of minimally-invasive surgical techniques have been introduced as a treatment to prevent glaucoma from progressing; ab interno trabecular bypass surgery with the Schlemm's canal Hydrus microstent is one of them.To evaluate the efficacy and safety of ab interno trabecular bypass surgery ...
Otarola F., Virgili G., Shah A., Hu K., Bunce C., Gazzard G.   +5 more
core   +9 more sources